{"entity":{"type":"insider","cik":"0001618364","url":"/insider/0001618364","json_url":"/insider/0001618364.json","name":"Nichols William Garrett","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2020-01-08","last":"2025-07-30","span_basis":"filed_date"},"name_variants":[{"name":"Nichols William Garrett","source":"filing","n_filings":8,"first_seen":"2024-07-15","last_seen":"2025-07-30"},{"name":"Nichols Garrett","source":"filing","n_filings":2,"first_seen":"2020-01-08","last_seen":"2020-02-11"}],"transactions":[{"id":4378503,"accession":"0000950170-25-100320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-100320","line_url":"/filing/0000950170-25-100320#line-2","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":937.0,"shares_display":"937","price_per_share":6.98,"price_display":"6.98","price_state":"stated","total_value":6540.26,"total_display":"6,540.26","total_whole":"6,540","shares_owned_after":52493.0,"shares_owned_after_display":"52,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":5033970,"accession":"0000950170-25-093035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-093035","line_url":"/filing/0000950170-25-093035#line-2","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":5.04,"price_display":"5.04","price_state":"stated","total_value":3936.24,"total_display":"3,936.24","total_whole":"3,936","shares_owned_after":52493.0,"shares_owned_after_display":"52,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-30","filed_date":"2025-07-02","scope":"insider"},{"id":5117548,"accession":"0000950170-25-042728","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-042728","line_url":"/filing/0000950170-25-042728#line-3","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45316.0,"shares_display":"45,316","price_per_share":8.7606,"price_display":"8.76","price_state":"stated","total_value":396995.3496,"total_display":"396,995.35","total_whole":"396,995","shares_owned_after":52493.0,"shares_owned_after_display":"52,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":4163150,"accession":"0000950170-25-006723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006723","line_url":"/filing/0000950170-25-006723#line-1","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10428.0,"shares_display":"10,428","price_per_share":7.225,"price_display":"7.22","price_state":"stated","total_value":75342.3,"total_display":"75,342.30","total_whole":"75,342","shares_owned_after":79320.0,"shares_owned_after_display":"79,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":4339668,"accession":"0000950170-25-004195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-004195","line_url":"/filing/0000950170-25-004195#line-1","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10799.0,"shares_display":"10,799","price_per_share":8.2183,"price_display":"8.22","price_state":"stated","total_value":88749.4217,"total_display":"88,749.42","total_whole":"88,749","shares_owned_after":89748.0,"shares_owned_after_display":"89,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":3036114,"accession":"0000950170-24-132928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-132928","line_url":"/filing/0000950170-24-132928#line-1","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13935.0,"shares_display":"13,935","price_per_share":4.5556,"price_display":"4.56","price_state":"stated","total_value":63482.286,"total_display":"63,482.29","total_whole":"63,482","shares_owned_after":100547.0,"shares_owned_after_display":"100,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-03","scope":"insider"},{"id":2637747,"accession":"0000950170-24-084759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084759","line_url":"/filing/0000950170-24-084759#line-1","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10875.0,"shares_display":"10,875","price_per_share":6.4726,"price_display":"6.47","price_state":"stated","total_value":70389.525,"total_display":"70,389.52","total_whole":"70,390","shares_owned_after":114482.0,"shares_owned_after_display":"114,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":3255259,"accession":"0000950170-24-083397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-083397","line_url":"/filing/0000950170-24-083397#line-1","is_derivative":false,"issuer_cik":"0001618364","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001618364","owner_cik":"0001618364","owner_name":"Nichols William Garrett","owner_display_name":"Nichols William Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9769.0,"shares_display":"9,769","price_per_share":5.9734,"price_display":"5.97","price_state":"stated","total_value":58354.1446,"total_display":"58,354.14","total_whole":"58,354","shares_owned_after":125357.0,"shares_owned_after_display":"125,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-15","scope":"insider"},{"id":2283731,"accession":"0001209191-20-008297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008297","line_url":"/filing/0001209191-20-008297#line-2","is_derivative":false,"issuer_cik":"0001117480","issuer_name":"CHIMERIX INC","issuer_ticker":"CMRX","issuer_name_source":null,"issuer_url":"/issuer/0001117480","owner_cik":"0001618364","owner_name":"Nichols Garrett","owner_display_name":"Nichols Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8805.0,"shares_display":"8,805","price_per_share":1.6843,"price_display":"1.68","price_state":"stated","total_value":14830.2615,"total_display":"14,830.26","total_whole":"14,830","shares_owned_after":260066.0,"shares_owned_after_display":"260,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":2283727,"accession":"0001209191-20-008297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008297","line_url":"/filing/0001209191-20-008297#line-1","is_derivative":false,"issuer_cik":"0001117480","issuer_name":"CHIMERIX INC","issuer_ticker":"CMRX","issuer_name_source":null,"issuer_url":"/issuer/0001117480","owner_cik":"0001618364","owner_name":"Nichols Garrett","owner_display_name":"Nichols Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2550.0,"shares_display":"2,550","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":4335.0,"total_display":"4,335.00","total_whole":"4,335","shares_owned_after":268871.0,"shares_owned_after_display":"268,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-11","scope":"insider"},{"id":2576580,"accession":"0001209191-20-002630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002630","line_url":"/filing/0001209191-20-002630#line-1","is_derivative":false,"issuer_cik":"0001117480","issuer_name":"CHIMERIX INC","issuer_ticker":"CMRX","issuer_name_source":null,"issuer_url":"/issuer/0001117480","owner_cik":"0001618364","owner_name":"Nichols Garrett","owner_display_name":"Nichols Garrett","owner_url":"/insider/0001618364","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30680.0,"shares_display":"30,680","price_per_share":2.1527,"price_display":"2.15","price_state":"stated","total_value":66044.836,"total_display":"66,044.84","total_whole":"66,045","shares_owned_after":271421.0,"shares_owned_after_display":"271,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001841387","name":"Candel Therapeutics, Inc.","url":"/issuer/0001841387","role":"Officer (Chief Medical Officer)","n_filings":8,"first_seen":"2024-07-15","last_seen":"2025-07-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001117480","name":"CHIMERIX INC","url":"/issuer/0001117480","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2020-01-08","last_seen":"2020-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618364","retrieved_at":"2026-08-25T11:39:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}